Most advice for lowering prescription drug costs misses the point, especially for people on Medicare. You hear the same things: switch to generics, use a discount card, shop around. But what do you do when your medication is a brand-name specialty drug with a price tag that looks more like a mortgage payment?
That question is becoming a frightening reality for millions, as industry research projects total U.S. prescription drug spending will surpass $1 trillion for the first time in 2026. It’s this high-stakes dilemma that a specialized service, SmartSaveMeds, was built to solve.
For over two decades, this advocacy service has focused on a powerful but little-known solution: enrolling eligible Medicare recipients directly into manufacturer-sponsored Patient Assistance Programs (PAPs). This approach is a world away from simple coupon cards and can create a pathway to potentially $0 costs for some of the most expensive medications on the market.











